{"name":"Dermira, Inc.","slug":"dermira-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Immunology","slug":"immunology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"DRM02","genericName":"DRM02","slug":"drm02","indication":"Plaque psoriasis","status":"phase_2"}]},{"name":"Dermatology","slug":"dermatology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"Olumacostat Glasaretil Gel, 5.0%","genericName":"Olumacostat Glasaretil Gel, 5.0%","slug":"olumacostat-glasaretil-gel-5-0","indication":"Acne vulgaris","status":"phase_3"}]}],"pipeline":[{"name":"DRM02","genericName":"DRM02","slug":"drm02","phase":"phase_2","mechanism":"DRM02 is a monoclonal antibody that targets CD40L.","indications":["Plaque psoriasis"],"catalyst":""},{"name":"Olumacostat Glasaretil Gel, 5.0%","genericName":"Olumacostat Glasaretil Gel, 5.0%","slug":"olumacostat-glasaretil-gel-5-0","phase":"phase_3","mechanism":"Olumacostat glasaretil inhibits sebum production by blocking sterol O-acyltransferase (SOAT1), reducing lipid accumulation in sebaceous glands.","indications":["Acne vulgaris"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxQTndjRmdiY2YxalptdWE0V2tvLXFjWUo5WmxjTzU2VmJwVldlQ2hBTjdVWU9ZalFtM3F5VGVmVGg2M2NGZ1ZhQVNobUMzOWNRZVpTR3V3U2QwVVltQlF0Mk1DQ0ZpUmRaeHNFV3h4QXFPZ19mQ0tZY3JjYk5NVmtCLXdPcWNnUTV3Vk5QVGVkbFMtdkV3R1FmTUtKQU1oRVRHSmZJNmhkeVRZdw?oc=5","date":"2025-10-09","type":"pipeline","source":"The Business Journals","summary":"Peninsula biotech Evommune puts skin in IPO game - The Business Journals","headline":"Peninsula biotech Evommune puts skin in IPO game","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixwFBVV95cUxOYUtxdWY1c202alBWR1hRTmxrbUg1dlN3VzNodTRWWExqSGNkU0RTZ3ZrSnV0UVJrM0x6Vm5CU2dPamFnNE4zb3IzUzZhTnV2T2VieHRSUWpWSjBMeVdHaE1Qb1NlRWc4TkZNaVducHV1Nm9telhBT3hQQnBfcG5vUWtjWnV3ZTBJbzMxTk5GdkgwNUMxUGVxQTBoSGRET3JyLVZRMFdyZVZPeXRCZFBjZ3g4SC15RFFNVzBpR05WNU1jUzVxMUJN?oc=5","date":"2021-09-09","type":"deal","source":"Fierce Biotech","summary":"Ex-Dermira founders pick up $83M for Evommune to advance programs in-licensed from Lilly's Dermira - Fierce Biotech","headline":"Ex-Dermira founders pick up $83M for Evommune to advance programs in-licensed from Lilly's Dermira","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikwFBVV95cUxPdHZIR0xIZmFNaV9BQzhMc0I1c0RtMGFiN25HeEhZdzNpTjYtbkRUYmFPeUt2MGJONUxIdTRpR25NX2VKSlh5X1I0b2ZaZndwVU5ZYm0ta0hPOHBlY1BxNGtuZkYyaWNoMjY0NTFnbmYwWVowcU1DendsdzFnM19wUnhWR1Z6ZEJjak53ZU1jYVlBV0k?oc=5","date":"2021-08-13","type":"pipeline","source":"SEC.gov","summary":"99.1 - SEC.gov - SEC.gov","headline":"99.1 - SEC.gov","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixAFBVV95cUxNeGlrdFdvQ2IwRExkb2NpUXJRMEdSc2lCOEFuQjNXQV90anhNU3RWa3JHOGk4NVRPYzRId1h5Q3pReERjTkdhc24tVmtVZV9JTERzX3MyWVVzU2ZDdFpEdWVndmJIZ3R4RVlIeEczN2JqbXBWTVdSZ3l2YXE3QzEyRFdsbjlyN2pIMDRDTWotTDhINDFuUk1hSFlhSWdFQUZTd2JvdTBmU3FIbE96MFlPZEJyNEhvY3BOVVhfM1plWnVpeVJn?oc=5","date":"2021-04-14","type":"deal","source":"Fierce Pharma","summary":"A year after buyout, Lilly to shutter Dermira's Menlo Park facility and shed 163 jobs - Fierce Pharma","headline":"A year after buyout, Lilly to shutter Dermira's Menlo Park facility and shed 163 jobs","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxOWHlzWVpMNXd6TmpYczV4Q2R3ZW1ZLTBkVjNaQUxNRWxuc2xnU2pjTGdLSnN4RmVMUnZqNC1rLXlmWTNuS2JwaTBwekJRR0hmMkl2UnF0b3hTalNmWWFOQUx3U1V1azhxWUtsdXRNOXNsVXV2cHBSVUhnSjBTS1plTmtidGxXeFoyVDRXZ1FsWmt4azVVYVNRWHU5NzRyUQ?oc=5","date":"2020-02-20","type":"pipeline","source":"Eli Lilly","summary":"Lilly Completes Acquisition of Dermira - Eli Lilly","headline":"Lilly Completes Acquisition of Dermira","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxOa0JtaFRxeXZkT0tFamdVMXktSWFqbHBLbEpvSmpUYVRUdHRFaWVfaGRIT2xHSWpkMVdxT2FNcGdMd1d1Mkt5Yk9USURKS0hQRXlMTHBNaHZsWVd2MlZIc1BLR1cyT1FyMlhXQlRzYUZ6d3dnVjgyM2Q1Tm9icUZwX0FLclBUakk0WllGNFY5TmVGcjYxQjJhNQ?oc=5","date":"2020-01-13","type":"deal","source":"MedCity News","summary":"Eli Lilly acquires skin disease-focused Dermira in $1.1B deal - MedCity News","headline":"Eli Lilly acquires skin disease-focused Dermira in $1.1B deal","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisAFBVV95cUxPYWR1d3BkVEdCQWNwNnhpNThuZTE1U3lHbk1xWjFncWxtZG5pV2kyNXdzZ1kwdUlBZWxZdTNpSGtFWTFEQjgxcjY1M05XYUxIQXFOd2hYcXFidlJiUVprVnJDSXFKam1NY1lUdVlVT2tsR05abzdLTmtsV2UtZ3Jhd05sS1BuRXpSY2NsSlBrdHRVa0QzTjdUY1RCTTNESzFhV25yUWlJSHh4Q2FaOUtLdQ?oc=5","date":"2020-01-10","type":"deal","source":"WFYI","summary":"Eli Lilly Acquires Dermatology Pharmaceutical Company Dermira For $1.1 Billion - WFYI","headline":"Eli Lilly Acquires Dermatology Pharmaceutical Company Dermira For $1.1 Billion","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxNQkpNSVlOczVQR1E2ZHNMUFVCb0Q4eDdqNGIzOHMzWkZyX1pMSWoxNHplNW9URUVTLXhpcWdVMDFWeVdHeFdNc1d5NUk0RXNyMGMzWklfaENwN1ZmQ2FVNEJtVm16cFd4TU5tdEtGaFlsb2E1WXRHQ2JWUmFjWVF1eHV3UUxqVzhBQ0dMM3FUNnl3MVdlNU9IanhENlZQMDRhNWZCUWdR?oc=5","date":"2020-01-10","type":"deal","source":"Eli Lilly","summary":"Lilly Announces Agreement to Acquire Dermira - Eli Lilly","headline":"Lilly Announces Agreement to Acquire Dermira","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipwFBVV95cUxNZlB6ZzY2VGd6Ry0zLXoyWlc0VFJHRU5VQ1JyUElqZ1hXdzd2UE0tdmNDU29lZW81WnR2SEpiN0ZZMXBFd2xPRnRNSk9ULUd2OWZTYU9ib1hkQUt3NWxrNC1iUk1hTkx1b3VieC0weW9TZlZjYWlGMVJuRl9sRVBCLWg2enh5VjRJX0pIdllIUGl0cUlVMDlDVElQUUFRNHN2Y1NjaksxUQ?oc=5","date":"2018-03-05","type":"pipeline","source":"Bloomberg.com","summary":"Dermira Reminds Investors What Binary Means in Biotech - Bloomberg.com","headline":"Dermira Reminds Investors What Binary Means in Biotech","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxNUTNfeGtPXzNfQjZEYlpyMTRfN09wNXZ1U2g4a0EwemVEVjFlYVRzMm85U1Z4TlBsbS1wdUluZWpBZFlWLXgxSWltSXduT0dnTG8tVzdfZk1JSGVmZE14Z0psLUJ4bF9Cdkc5eHV0dGNnTHBXM2E3RUJoS09fTVBtdzZHZ1JzWll5VVNVamF6VEFISEI5NmtPVmQyQWJUYVlxcExwQVdjTzNPeVRz?oc=5","date":"2017-10-11","type":"pipeline","source":"Northwestern University","summary":"Northwestern Alumni Return to Share Insight Into Industry - Northwestern University","headline":"Northwestern Alumni Return to Share Insight Into Industry","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipwFBVV95cUxPNml5dGdMdVZVTVpNR3JOLWRvYjV3OGI3OUJGcy1jQ0JrcDBjczRlNXF0WTkza3NoSXNxSlZfMEtPdjdNbmtYaVNjYjFtZVV2QThzS0ZnLVdVY3Q3Z3lYb3pFNmF2WkxJN2RWbjJhYng2Q2FmVk4waGI3bk9JMzAzU1d2VGQ4Z3UxVGwyUXg0cERCcENETU1uLVRwbk92akdkQS1RXzFBMA?oc=5","date":"2017-08-08","type":"pipeline","source":"BioPharma Dive","summary":"Roche sells off dermatitis drug to Dermira - BioPharma Dive","headline":"Roche sells off dermatitis drug to Dermira","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi6wFBVV95cUxPZ2JDZ0FLU1FHazRSSGJzUkdtNkI3ZXV2WDdzRm96al9Ecy1EZGM5ai1lZFlZemxHV1NhWEp5Qm0zNURFM0kxVkV2R3FsYkJ2YllpeWctSkZoVGY4RjVmZWU4V0FSUUU0TUUwNzJCdDZsaUZ5cGNZOWxpZ045VXNYeHpwejVPN0lwNFlCb1duYVJUakxFQ1NoWVpvWndRTEJMRVNIM0xSZGJDcEJPYkF3N1hobTI1MnR0dldrenNqUEhKaFRMYjVJVU1PTkdXeW5lYVdvTVhuVW9NdXlKUXVVSkpFUU5UNklaVVZ3?oc=5","date":"2017-08-08","type":"deal","source":"GlobeNewswire","summary":"Dermira Enters into Agreement to License Exclusive, Worldwide Rights to Lebrikizumab - GlobeNewswire","headline":"Dermira Enters into Agreement to License Exclusive, Worldwide Rights to Lebrikizumab","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"phase_2":1,"phase_3":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}